From idea to reality
Our BioVenture Studio bridges the gap between science and business to build game-changing institutions that accelerate scientific and medical breakthroughs.
NJK+A BioVenture Studio works to evaluate the state and value of transformative discoveries to create opportunities for investment and growth.
Building a Human Genome from Scratch
Genome Foundry @ISG
We have in-depth knowledge of the business, government, non-profit and academic sectors across the country.
NJK+A Game Changers:
- NJK+A led the development of the New York Genome Center from a start up to a fully operational, world-class genomics sequencing and research center, the first of its kind in NYC.
- NJK+A helped launch and finance Biodesign Challenge, a first-of-its-kind education and competition that is shaping the first generation of biodesigners.
NJK+A Bioventure Studio • Related Videos
Featured Projects
CONNECTOR HUBS
Connector Hubs creates a new model for advancing life science innovation, one that channels private capital toward breakthrough research, strengthens regional innovation. This accelerates the translation of discovery into impact, and helps rebuild U.S. leadership across science, technology, and biotechnology. The result is a more resilient, and effective innovation ecosystem capable of turning today's scientific discoveries into tomorrow's solutions.
KYTTARO THERAPEUTICS
Nancy J Kelley + Associates conducted an extensive technology evaluation and due diligence on the patent portfolio of Apceth Biopharma and brought in business partners to form a US Delaware corporation named Kyttaro Therapeutics with exclusive rights to the patent portfolio. NJK+A then formed a Scientific Advisory Board, created partnerships with a global clinical research organization for clinical trials management, and engaged clinical partners from high quality US universities, thereby positioning the company for fundraising.
In-depth Knowledge
“Nancy J Kelley + Associates brought an experienced, multi-disciplinary team with in-depth knowledge of medical genomics and the changing nature of diagnostic testing to assist Roswell Park Cancer Institute in forming and spinning out an advanced diagnostic testing commercial venture, thereby positioning RPCI to be a real player in the field of cancer genomics.”
Candace Johnson, PhD, President and CEO,
Roswell Park Cancer Institute
Cancer Center Director;
Chair, Pharmacology and Therapeutics
Wallace Family Chair of Translational Research
From an Idea to Reality
“Nancy J. Kelley was instrumental in nurturing the New York Genome Center from an idea to a reality, to the inestimable benefit of scientific research and New York City.”
Russ Carson and Ivan Seidenberg
Co-Chairs of the NYGC Board of Directors
Invaluable Resource for a Successful Launch
“When I decided to start the Biodesign Challenge, Nancy J Kelley + Associates was the natural choice as a partner. Knowledgeable and highly experienced in all aspects of start-up organizations, their team was an invaluable resource for helping launch and finance a successful organization and a successful project.”
Dan Grushkin
Founder, Biodesign Challenge
Founder and Executive Director, GenSpace
BRIDGING THE GAP BETWEEN SCIENCE & BUSINESS
“Nancy J Kelley + Associates brought a collaborative approach and strategic perspective that bridged the gap between science and business to launch a successful personalized genomic medicine company for Roswell Park Cancer Institute. Their ability to coordinate a series of complex partnerships across a broad array of scientific and technological disciplines was invaluable to the success of the venture.”
Donald L. Trump, MD, FACP CEO and Executive Director
Inova Comprehensive Cancer Research Institute
Inova Health System CEO Emeritus and Professor of Oncology
Roswell Park Cancer Institute
UNDERSTANDING THE PRACTICAL IMPLICATIONS OF GENETIC TECHNOLOGY
“The GP-write grand challenge is more ambitious and more focused on understanding the practical applications than the original Human Genome Project. Exponential improvements in genome engineering technologies and functional testing provide an opportunity to deepen the understanding of our genetic blueprint and use this knowledge to address many of the global problems facing humanity.”
George Church, PhD; Professor of Genetics, Harvard Medical School
Core Faculty Member, Wyss Institute for Biologically Inspired Engineering
